$5.39
At close: Apr 8 EDT
$5.13
-0.26-4.82%
Pre-Market: 5:06 PM EDT
Comments
Loading...
Corbus Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:CRBP | Benzinga
Corbus Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS Estimate
$-1.410
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Corbus Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CRBP | Corbus Pharmaceuticals | -$0.83 | -$1.41 | — | — | $0.00 | — | — | — | 05/06/2025 | Get Alert |
| CRBP | Corbus Pharmaceuticals | -$1.81 | -$1.22 | -$0.78 | 36.07% | $0.00 | — | $0.00 | — | 03/11/2025 | Get Alert |
| CRBP | Corbus Pharmaceuticals | -$2.27 | -$0.95 | -$1.15 | -21.05% | $0.00 | — | $0.00 | — | 11/07/2024 | Get Alert |
| CRBP | Corbus Pharmaceuticals | -$2.05 | -$1.26 | -$0.90 | 28.57% | $0.00 | — | $0.00 | — | 08/06/2024 | Get Alert |
| CRBP | Corbus Pharmaceuticals | -$4.24 | -$1.52 | -$0.83 | 45.39% | $0.00 | — | $0.00 | — | 05/07/2024 | Get Alert |
| CRBP | Corbus Pharmaceuticals | -$2.61 | -$2.36 | -$1.81 | 23.31% | $0.00 | — | $0.00 | — | 03/12/2024 | Get Alert |
| CRBP | Corbus Pharmaceuticals | -$2.10 | -$2.06 | -$2.27 | -10.19% | $0.00 | — | $0.00 | — | 11/07/2023 | Get Alert |
| CRBP | Corbus Pharmaceuticals | -$2.10 | -$3.10 | -$2.05 | 33.87% | $0.00 | — | $0.00 | — | 08/08/2023 | Get Alert |
| CRBP | Corbus Pharmaceuticals | -$2.40 | -$4.09 | -$4.24 | -3.67% | $0.00 | — | $0.00 | — | 05/09/2023 | Get Alert |
| CRBP | Corbus Pharmaceuticals | -$2.40 | -$2.10 | -$2.61 | -24.29% | $0.00 | — | $0.00 | — | 03/07/2023 | Get Alert |
| CRBP | Corbus Pharmaceuticals | -$0.60 | -$1.50 | -$2.10 | -40.00% | $97.32K | $0.00 | $0.00 | — | 11/08/2022 | Get Alert |
| CRBP | Corbus Pharmaceuticals | -$4.50 | -$1.80 | -$2.10 | -16.67% | $136.56K | $100.00K | $0.00 | -100.00% | 08/09/2022 | Get Alert |
| CRBP | Corbus Pharmaceuticals | -$4.20 | -$2.40 | -$2.40 | 0.00% | $647.82K | $150.00K | $0.00 | -100.00% | 05/10/2022 | Get Alert |
| CRBP | Corbus Pharmaceuticals | -$3.00 | -$3.30 | -$2.40 | 27.27% | $658.20K | $350.00K | $0.00 | -100.00% | 03/08/2022 | Get Alert |
| CRBP | Corbus Pharmaceuticals | -$12.90 | -$3.30 | -$0.60 | 81.82% | $1.23M | $650.00K | $97.32K | -85.03% | 11/12/2021 | Get Alert |
| CRBP | Corbus Pharmaceuticals | -$15.60 | -$3.60 | -$4.50 | -25.00% | $286.35K | $870.00K | $136.56K | -84.30% | 08/12/2021 | Get Alert |
| CRBP | Corbus Pharmaceuticals | -$12.90 | -$4.50 | -$4.20 | 6.67% | $1.76M | $960.00K | $647.82K | -32.52% | 05/13/2021 | Get Alert |
| CRBP | Corbus Pharmaceuticals | -$12.30 | -$7.50 | -$3.00 | 60.00% | $2.57M | $1.49M | $658.20K | -55.83% | 03/15/2021 | Get Alert |
| CRBP | Corbus Pharmaceuticals | -$9.60 | -$12.60 | -$12.90 | -2.38% | $2.59M | $2.31M | $1.23M | -46.71% | 11/10/2020 | Get Alert |
| CRBP | Corbus Pharmaceuticals | $0.90 | -$11.70 | -$15.60 | -33.33% | $29.09M | $2.99M | $286.35K | -90.42% | 08/06/2020 | Get Alert |
| CRBP | Corbus Pharmaceuticals | -$12.90 | -$12.00 | -$12.90 | -7.50% | $1.89M | $2.41M | $1.76M | -26.89% | 05/11/2020 | Get Alert |
Corbus Pharmaceuticals (CRBP) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-11 | $-0.78 | $-1.22 | 36.1 % |
| Q3 | 2024-11-07 | $-1.15 | $-0.95 | -21.1 % |
| Q2 | 2024-08-06 | $-0.90 | $-1.26 | 28.6 % |
| Q1 | 2024-05-07 | $-0.83 | $-1.52 | 45.4 % |
Corbus Pharmaceuticals (CRBP) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | 2022-08-09 | $0 | $100.00K | -100.0 % |
| Q1 | 2022-05-10 | $0 | $150.00K | -100.0 % |
| Q4 | 2022-03-08 | $0 | $350.00K | -100.0 % |
| Q3 | 2021-11-12 | $97.32K | $650.00K | -85.0 % |
FAQ
When is Corbus Pharmaceuticals (NASDAQ:CRBP) reporting earnings?
Corbus Pharmaceuticals (CRBP) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on March 11, 2025 for Q4.
What were the latest earnings per share (EPS) for Corbus Pharmaceuticals (NASDAQ:CRBP)?
The Actual EPS was $-0.78, which beat the estimate of $-1.22.
What were Corbus Pharmaceuticals’s (NASDAQ:CRBP) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.